Cancer Treatment in India for Ethiopian Patients: Cost in Birr, USD, INR

Cancer treatment in India for Ethiopian patients covers all major cancer types including breast, cervical, prostate, lung, blood, and brain cancers, with costs ranging from 168,000 to 2,800,000 Birr depending on cancer type and stage. India offers internationally accredited oncology care at 60 to 75% lower cost than Europe or the United States, with five-year survival rates comparable to leading Western centers.

Why This Guide Matters for Ethiopian Patients

Cancer incidence in Ethiopia has been rising steadily over the past decade, driven by changing lifestyles, longer life expectancy, and improved diagnostic capacity. The country's primary oncology infrastructure sits at Tikur Anbessa Specialized Hospital, the main cancer treatment center serving more than 120 million people. Bethel Teaching Hospital, Hallelujah General Hospital, and a small number of private centers in Addis Ababa provide additional capacity, but advanced cases routinely face waitlists measured in months, and certain protocols such as bone marrow transplantation or specialized radiotherapy remain limited or unavailable locally.

For families confronting a cancer diagnosis, the options narrow quickly. Treatment in Europe or the United States offers world-class care but carries costs that are five to ten times higher than India. Treatment in Turkey or Thailand is sometimes considered, but cost, language familiarity, flight connections, and community presence make India the most common choice for Ethiopian patients. Ethiopian Airlines operates direct flights from Addis Ababa Bole International Airport to Delhi and Mumbai, the Ethiopian community in India is well-established, and major Indian hospitals have invested in Amharic interpreter services specifically for African patients.

This guide covers what cancer is, how it is classified, how it is treated in India, what each treatment costs, and how Ethiopian patients access care from first contact to follow-up after returning home.

What is cancer?

Cancer is a disease in which abnormal cells in the body grow uncontrollably, dividing without stopping, invading nearby tissues, and sometimes spreading to other organs through the blood or lymphatic system.

In a healthy body, cells grow, divide, and die in an orderly process. Old cells die off and new cells replace them. Cancer disrupts this process. Cells that should die continue to live. New cells form when they are not needed. These extra cells can form a mass called a tumor.

The disruption is caused by damage to the DNA inside cells. DNA is the instruction manual that tells cells when to grow, when to divide, and when to die. When DNA is damaged through inherited factors, environmental exposures, or random mutations, the instructions can get corrupted. Cells stop following normal rules. They keep dividing. They ignore signals to stop.

Not every tumor is cancer. Benign tumors stay in one place and do not spread. They can grow large and cause problems by pressing on surrounding tissue, but they do not invade other parts of the body. Malignant tumors are different. They invade nearby tissues, and pieces of the tumor can break off, travel through the blood or lymph system, and form new tumors in distant organs. This spread is called metastasis, and it is what makes cancer dangerous.

In Amharic, ካንሰር (kānsar) is the term used across all regions of Ethiopia. Older Amharic terms such as ድንቅ በሽታ (the strange disease) are still occasionally heard in rural areas, often reflecting how the disease was once feared and misunderstood.

What are the main types of cancer?

Cancer is classified by the organ or tissue where it starts, with over 100 distinct types, but most cancers fall into five main categories: carcinomas, sarcomas, leukemias, lymphomas, and central nervous system cancers.

Carcinomas

Carcinomas are the most common type of cancer, accounting for 80 to 90% of all cancer cases. They begin in skin or in tissues that line or cover internal organs. The major carcinomas that affect Ethiopian patients include:

Breast cancer starts in the cells of the breast and is the most common cancer in Ethiopian women, often diagnosed at later stages due to delayed presentation. Cervical cancer begins in the cells of the cervix and remains one of the leading causes of cancer death in Ethiopian women, largely because human papillomavirus (HPV) vaccination coverage remains limited. Lung cancer begins in the lungs and is increasing in Ethiopia in line with tobacco use patterns. Colon cancer starts in the large intestine and is rising as dietary patterns shift. Prostate cancer affects older Ethiopian men and is often diagnosed late due to limited screening programs. Stomach cancer is more common in Ethiopia than in many Western countries, partly due to high rates of Helicobacter pylori infection. Liver cancer is associated with chronic hepatitis B infection, which has significant prevalence in Ethiopia.

Sarcomas

Sarcomas are rare cancers that begin in bone, cartilage, fat, muscle, blood vessels, or connective tissue. Bone sarcoma most commonly affects children and young adults. Soft tissue sarcomas can occur anywhere in the body. Sarcomas require specialized surgical and oncological expertise that is limited in Ethiopia and routinely necessitates treatment abroad.

Leukemias

Leukemias are cancers that start in blood-forming tissue, particularly the bone marrow, causing the body to produce large numbers of abnormal white blood cells. There are four main types. Acute Lymphoblastic Leukemia (ALL) is the most common cancer in children and progresses rapidly without treatment. Acute Myeloid Leukemia (AML) is the most common acute leukemia in adults and also progresses rapidly. Chronic Lymphocytic Leukemia (CLL) tends to affect older patients and progresses slowly. Chronic Myeloid Leukemia (CML) is highly treatable today with targeted therapies that have transformed it from a fatal disease into a chronic, manageable condition.

For Ethiopian patients with leukemia, the most common diagnoses based on patterns seen at Tikur Anbessa are AML in adults and ALL in children. For comprehensive information on this category, read our complete guide to leukemia treatment in India for Ethiopian patients.

Lymphomas

Lymphomas are cancers that begin in cells of the immune system called lymphocytes. They fall into two main categories. Hodgkin's lymphoma is less common but highly treatable, with cure rates exceeding 80% in most stages. Non-Hodgkin's lymphoma is more common and encompasses a wide range of subtypes with varying treatment approaches. Both are treatable in India with internationally standardized protocols.

Central Nervous System Cancers

Central nervous system cancers begin in tissues of the brain and spinal cord. Glioma is the most common type of primary brain tumor in adults. Meningioma originates in the membranes covering the brain and is often benign. Pituitary tumors affect hormone production. Pediatric brain tumors require specialized neurosurgical and oncology teams, capacity that is highly limited in Ethiopia and routinely accessed in India.

What causes cancer?

Cancer is caused by changes (mutations) to the DNA within cells, with causes including genetic factors, lifestyle factors, environmental exposures, certain viral infections, and aging.

Genetic factors

Some cancers run in families due to inherited gene mutations. BRCA1 and BRCA2 mutations significantly increase the risk of breast and ovarian cancer. Lynch syndrome increases the risk of colon and other cancers. A strong family history of cancer, particularly cancers diagnosed before age 50, can be a sign of inherited risk. Genetic testing is increasingly available at major Indian hospitals and is recommended when family history suggests inherited risk.

Lifestyle factors

Tobacco use is responsible for roughly 22% of cancer deaths globally and causes cancers of the lung, mouth, throat, esophagus, stomach, pancreas, bladder, and cervix. Alcohol consumption increases the risk of cancers of the mouth, throat, esophagus, liver, breast, and colon. Diet patterns high in processed meat and low in fruits and vegetables increase cancer risk. Obesity is linked to at least 13 types of cancer. Physical inactivity also raises cancer risk independent of weight.

Environmental and occupational exposures

Ultraviolet radiation from the sun causes most skin cancers. Air pollution is now classified as a definite cause of lung cancer. Chemical exposures including asbestos, certain pesticides, and industrial chemicals can cause cancer with long-term exposure. Indoor air pollution from biomass cooking fuels, common in rural Ethiopia, is associated with elevated lung cancer risk.

Infectious agents

Several infections cause cancer. Human papillomavirus (HPV) is responsible for the majority of cervical cancer cases and is a major cause of cervical cancer in Ethiopian women. Hepatitis B and C cause liver cancer, with chronic hepatitis B being particularly relevant for Ethiopia due to its prevalence. Helicobacter pylori bacteria cause stomach cancer and ulcers, and Ethiopia has high H. pylori infection rates. HIV-related immune suppression increases risk for several cancers including Kaposi's sarcoma and certain lymphomas.

Age and biological factors

Cancer risk increases significantly with age because DNA damage accumulates over time and the body's repair mechanisms become less efficient. Hormonal factors influence cancers such as breast, prostate, ovarian, and endometrial cancer. Most cancers are diagnosed in patients over age 50, though childhood and young adult cancers do occur and require specialized pediatric oncology care.

What are the early warning signs of cancer?

Early warning signs of cancer vary by cancer type but include unexplained weight loss, persistent fatigue, unusual lumps or swelling, persistent pain, changes in bowel or bladder habits, persistent cough, and unexplained bleeding.

General warning signs of any cancer

Unexplained weight loss of more than 10 pounds without trying. Persistent fatigue that does not improve with rest. Unusual lumps, thickening, or swelling anywhere on the body. Persistent pain in a specific area without clear cause. Skin changes including sores that do not heal, changes in moles, or new growths. Persistent cough or hoarseness lasting more than three weeks. Difficulty swallowing. Unusual bleeding or discharge from any body opening.

Cancer-specific warning signs

Breast cancer presents as a lump in the breast or armpit, changes in breast shape or size, nipple discharge or inversion, and skin changes on the breast such as dimpling or redness. Cervical cancer signs include abnormal bleeding between periods, after intercourse, or after menopause, along with pelvic pain and unusual vaginal discharge. Lung cancer often presents with persistent cough, coughing up blood, chest pain, shortness of breath, and recurrent chest infections. Colon cancer signs include changes in bowel habits, blood in stool, persistent abdominal discomfort, and unexplained iron deficiency anemia. Leukemia presents with persistent fatigue, frequent infections, easy bruising, bone pain, and pale skin. Brain tumor symptoms include persistent headaches that worsen over time, vision changes, seizures, balance problems, and personality changes. Stomach cancer signs include persistent indigestion, feeling full after small meals, unexplained weight loss, and dark stools.

Critical warning for Ethiopian patients

Many of these symptoms are commonly misdiagnosed in Ethiopia as anemia, typhoid, gastric infection, or general fatigue. The combination of limited access to specialist diagnostics and the high prevalence of common infectious diseases means cancer symptoms are often treated as something else for weeks or months before the correct diagnosis is made.

If symptoms persist beyond two weeks despite treatment for an assumed condition, request a complete blood count (CBC). If the CBC shows abnormalities or if symptoms continue, insist on further investigation including imaging or biopsy. Early diagnosis is the single largest factor in cancer treatment success. A cancer caught at Stage I has dramatically better treatment outcomes than the same cancer caught at Stage IV.

How is cancer diagnosed?

Cancer is diagnosed through a combination of physical examination, imaging tests, laboratory tests, and biopsy, with biopsy being the definitive method for confirming cancer.

Physical examination

A doctor checks for lumps, abnormal swelling, skin changes, or other signs of disease. This is the starting point of cancer diagnosis and remains essential, but it cannot confirm cancer on its own.

Imaging tests

X-rays detect bone cancers and lung cancers. Ultrasound examines soft tissue, abdominal organs, and the reproductive system. Computed tomography (CT) scan creates detailed cross-sectional images and is used for nearly every cancer type. Magnetic resonance imaging (MRI) provides high-resolution images of brain, spine, and soft tissues. Positron emission tomography (PET) scan detects cancer activity throughout the body and is particularly useful for staging.

Laboratory tests

Complete blood count (CBC) reveals leukemia and lymphoma indicators. Tumor marker tests include prostate-specific antigen (PSA) for prostate cancer, CA-125 for ovarian cancer, CEA for colon cancer, and alpha-fetoprotein for liver cancer. Pap smear screens for cervical cancer. Liver and kidney function tests assess overall health and detect cancer spread.

Biopsy

Biopsy is the definitive method for diagnosing cancer. A small sample of tissue is removed and examined under a microscope by a pathologist. Needle biopsy uses a thin needle to extract tissue. Surgical biopsy removes a larger sample through a small surgical procedure. Bone marrow biopsy is essential for diagnosing blood cancers. Without biopsy confirmation, a cancer diagnosis cannot be considered definitive.

Genetic testing

Genetic testing is recommended when family history suggests inherited cancer risk. BRCA testing is offered for breast and ovarian cancer risk. Hereditary syndrome panels test for multiple inherited cancer risks at once.

For Ethiopian patients, basic diagnostic capacity exists at Tikur Anbessa, SPHMMC, and Bethel Hospital. Advanced imaging such as PET-CT remains limited and may require travel. Specialized molecular and genetic testing often requires sending samples abroad. Many Ethiopian patients begin the diagnostic process locally with CBC, ultrasound, and basic biopsies, then complete advanced staging in India where results are faster and treatment can begin immediately.

What are the stages of cancer and why do they matter?

Cancer staging describes how far cancer has spread in the body, ranging from Stage 0 (very early, contained) to Stage IV (advanced, spread to distant organs). The stage determines treatment approach, intensity, and prognosis.

The four main stages

Stage 0, also called carcinoma in situ, means abnormal cells are present but have not spread to nearby tissue. This is the earliest possible cancer and is highly treatable, often curable with surgery alone.

Stage I means cancer is small and contained within the organ where it started. Treatment usually involves surgery alone, with high cure rates exceeding 80% for most cancer types.

Stage II means cancer has grown larger or spread to nearby lymph nodes. Treatment typically involves surgery combined with chemotherapy or radiation. Cure rates remain strong, typically 60 to 80%.

Stage III means cancer has spread to nearby tissues and multiple lymph nodes. Treatment is multi-modal, combining surgery, chemotherapy, radiation, and sometimes targeted therapy. Cure rates vary by cancer type but five-year survival is meaningful and improving.

Stage IV means cancer has spread to distant organs. This is called metastatic cancer. Treatment focuses on extending life, controlling symptoms, and maintaining quality of life. Some Stage IV cancers, particularly those responsive to modern targeted therapies and immunotherapies, can be controlled for many years.

TNM staging system

Oncologists worldwide use the TNM system. T (Tumor) describes the size and extent of the main tumor. N (Nodes) describes whether cancer has spread to nearby lymph nodes. M (Metastasis) describes whether cancer has spread to distant parts of the body. A cancer staged as T2 N1 M0 means a moderate-sized tumor that has reached nearby lymph nodes but has not yet metastasized.

Why staging matters for Ethiopian patients

Stage at diagnosis is the single most important factor in cancer outcomes. Ethiopian patients are often diagnosed at Stage III or Stage IV because of delayed symptom recognition, limited screening programs, and slow access to diagnostic services. Travel to India does not change the cancer stage. But treatment options available in India often include advanced protocols, modern targeted therapies, and immunotherapies that are not available in Ethiopia. Even Stage IV cancers that cannot be effectively treated locally often have meaningful treatment options at Indian centers.

What are the main cancer treatment options?

The main cancer treatment options include surgery, chemotherapy, radiation therapy, targeted therapy, immunotherapy, hormone therapy, and stem cell transplant, often used in combination based on cancer type and stage.

Surgery

Surgery removes the cancer physically. It is used for solid tumors that can be reached and removed, and it is often the first treatment for early-stage cancers. The surgeon removes the tumor and sometimes surrounding tissue or lymph nodes to ensure no cancer cells are left behind. Recovery time depends on the location and extent of surgery, typically ranging from a few days to several weeks.

Chemotherapy

Chemotherapy uses drugs to kill rapidly dividing cells. It is used for blood cancers, advanced cancers, and before or after surgery in many solid tumors. Drugs are delivered through intravenous infusion, oral tablets, or injection. Side effects include hair loss, fatigue, nausea, lowered immunity, and increased infection risk. Modern protocols manage these side effects far better than in previous decades. Treatment is given in cycles, typically with weeks of treatment followed by recovery periods.

Radiation therapy

Radiation therapy uses high-energy beams to kill cancer cells in a specific location. It is used for localized cancers, after surgery to kill any remaining cancer cells, or to relieve symptoms in advanced disease. External beam radiation is delivered from a machine outside the body. Internal radiation, called brachytherapy, places radioactive material inside or near the cancer. Treatment courses typically span several weeks of daily sessions.

Targeted therapy

Targeted therapy uses drugs that attack specific features of cancer cells. It is used for cancers that have specific genetic markers identifiable by testing. Examples include tyrosine kinase inhibitors for CML, which have transformed this disease from rapidly fatal to long-term manageable, and HER2 inhibitors for HER2-positive breast cancer. Side effects are typically fewer and more manageable than traditional chemotherapy because the treatment is more precise.

Immunotherapy

Immunotherapy uses drugs that help the body's immune system recognize and attack cancer cells. It has transformed treatment of advanced melanoma, lung cancer, kidney cancer, and certain lymphomas. Indian centers now offer immunotherapy protocols comparable to leading Western institutions, and these treatments are accessible to Ethiopian patients at significantly lower cost than equivalent treatment abroad.

Hormone therapy

Hormone therapy blocks hormones that fuel certain cancers. It is used primarily for breast cancer and prostate cancer, which can be driven by estrogen and testosterone respectively. Treatment is often long-term, continuing for years after primary treatment ends.

Stem cell transplant

Stem cell transplant, also called bone marrow transplant, replaces diseased bone marrow with healthy stem cells. It is used for blood cancers including leukemia, lymphoma, and multiple myeloma, and for certain solid tumors. Autologous transplant uses the patient's own cells, harvested before chemotherapy. Allogeneic transplant uses cells from a matched donor. This is a significant treatment requiring extended hospital stay and careful follow-up. India is one of the world's largest providers of stem cell transplants and offers them at a fraction of Western costs.

Indian oncology centers offer all seven treatment modalities at internationally accredited standards, often combining them in ways that maximize survival and quality of life.

How is cancer treated in India for international patients?

Cancer treatment in India for international patients follows internationally accepted protocols at NABH and JCI accredited hospitals, with multidisciplinary tumor boards reviewing complex cases and personalized treatment plans built around the patient's diagnosis, stage, and overall health.

The treatment process for Ethiopian patients typically follows these steps. Before arrival, medical reports are sent to Indian oncologists for initial assessment and treatment recommendation. A cost estimate is provided within 48 hours. The patient arrives in India and undergoes confirmatory tests at the Indian hospital. A multidisciplinary tumor board reviews the case and finalizes the treatment plan. Treatment is delivered per the agreed plan, with adjustments as response is monitored. The patient recovers in-hospital and receives post-treatment monitoring. Upon discharge, the patient receives a detailed follow-up plan and medications for the return to Ethiopia.

What makes Indian oncology comparable to Western centers includes internationally trained oncologists, many with fellowship training in the United States, United Kingdom, or Europe. The same medications and protocols are available. The same imaging and diagnostic technology including PET-CT, advanced MRI, and molecular pathology is in routine use. NABH and JCI accreditation enforces international quality standards. Multidisciplinary tumor boards bring together surgical oncologists, medical oncologists, radiation oncologists, pathologists, and radiologists to review complex cases together.

For Ethiopian patients specifically, major Indian hospitals offer Amharic interpreter services at no additional cost. Halal food options are routinely available. Orthodox fasting accommodation during treatment is supported where medically safe. Proximity to the Indian Embassy of Ethiopia in Delhi and to the established Ethiopian community in nearby neighborhoods makes the experience less isolating for patients and accompanying family.

How much does cancer treatment cost in India by cancer type?

Cancer treatment costs in India for Ethiopian patients range from 168,000 Birr for early-stage cancers to over 2,800,000 Birr for advanced cases requiring multi-modal treatment.

What is included in these costs: surgeon and oncologist fees, hospitalization, surgery, standard medications during the treatment course, and basic post-treatment review.

What is not included: travel to and from India, accommodation outside hospital stays, food, attendant expenses, and post-treatment medications for the return to Ethiopia.

Cost ranges are based on DocTrePat partner hospital indicative quotes. Exchange rates used: 1 USD = 56 Birr = 83 INR as of June 2026. Actual treatment cost requires personalized assessment based on the patient's medical reports.

Get a personalized cancer treatment cost estimate based on your reports within 48 hours. Message us on WhatsApp.

What additional costs should Ethiopian families plan for?

Beyond treatment, Ethiopian families should budget approximately 56,000 to 168,000 Birr (USD 1,000 to USD 3,000) for travel, accommodation, food, and one attendant's expenses during the treatment period.

DocTrePat coordinates most logistics including airport pickup, accommodation booking, money exchange referrals, and Amharic interpreter arrangements free of charge for Ethiopian patients. Hospital negotiations through DocTrePat typically reduce the overall cost below the initial published quote, particularly for extended treatment courses.

Which Indian hospitals are best for cancer treatment for Ethiopian patients?

Leading Indian hospitals for cancer treatment for Ethiopian patients include BLK Max Hospital Delhi, Fortis Memorial Research Institute Gurugram, Medanta The Medicity, and Apollo Hospitals, all NABH and JCI accredited with dedicated international patient and Amharic interpreter services.

BLK Max Super Specialty Hospital in Delhi operates one of North India's largest oncology departments with 100+ beds dedicated to cancer care. The hospital is NABH and JCI accredited and treats more than 5,000 international patients annually, with a substantial portion from Ethiopia and other African countries. Lead oncology specialists at BLK Max have international fellowship training and the hospital provides Amharic interpreter services on request.

Fortis Memorial Research Institute in Gurugram is a quaternary care facility known for advanced cancer treatment including precision oncology, immunotherapy, and bone marrow transplantation. It carries NABH and JCI accreditation and operates a dedicated international patient services division with experience handling Ethiopian patients. Cost negotiations through DocTrePat typically secure preferential rates for Ethiopian families.

Medanta The Medicity in Gurugram houses the Medanta Cancer Institute, a comprehensive cancer center with leading specialists across surgical oncology, medical oncology, and radiation oncology. The institute treats high volumes of international patients and offers advanced protocols including CAR-T cell therapy for select blood cancers.

Apollo Hospitals operates multiple cancer centers across India, with the Apollo Cancer Institutes in Chennai and Delhi being the most commonly used by Ethiopian patients. Apollo has the longest history of treating international patients of any Indian hospital group and offers established care pathways specifically designed for African patients.

DocTrePat partner hospitals are selected based on clinical outcomes, NABH and JCI accreditation, international patient services capability, and demonstrated experience treating Ethiopian patients. Hospital selection for each patient is based on the specific cancer type, stage, and treating specialist recommendation rather than a one-size-fits-all approach.

What is the success rate of cancer treatment in India?

Five-year survival rates for cancer treatment in India for international patients range from 60 to 90% depending on cancer type and stage at diagnosis, comparable to leading Western centers.

These figures are for cancers diagnosed at early stages. Outcomes for cancers diagnosed at Stage III or Stage IV are meaningfully lower across all types and all geographies, which underscores why early detection matters so much.

A critical observation for Ethiopian patients: when local cancer outcomes data is reported as lower than international rates, the gap is largely attributable to later-stage diagnosis rather than inferior treatment quality where treatment is available. Ethiopian patients who reach India at any stage receive the same protocol standards as patients from anywhere else. Even advanced cases that have limited options in Ethiopia often have meaningful treatment options at Indian centers.

How does an Ethiopian patient travel to India for cancer treatment?

Ethiopian cancer patients travel to India by obtaining an Indian medical visa, flying Ethiopian Airlines from Addis Ababa Bole to Delhi or Mumbai, and being received at the airport by their hospital coordinator.

The three-step process is straightforward. First, the patient or family submits medical reports to DocTrePat. The reports are reviewed by an Indian oncologist within 48 hours, a treatment plan and cost estimate are provided, and the hospital issues a formal invitation letter required for medical visa application.

Second, the patient applies for an Indian medical visa at the Indian Embassy in Addis Ababa. Processing time is typically 5 to 10 working days for standard cases and can be expedited to 2 to 3 days for urgent cases with hospital support. A companion visa for one attendant is processed simultaneously.

Third, the patient books Ethiopian Airlines from Addis Ababa Bole International Airport to either Indira Gandhi International Airport in Delhi or Chhatrapati Shivaji International Airport in Mumbai. Daily direct flights operate to both destinations. Upon arrival, a DocTrePat representative receives the patient at the airport and accompanies the patient directly to the hospital or accommodation.

The total timeline from first contact to arrival at the Indian hospital is typically 14 to 21 days for non-emergency cases. Urgent cases can be accelerated to 7 to 10 days when hospital admission is required immediately.

What about follow-up after returning to Ethiopia?

Post-treatment follow-up for Ethiopian cancer patients includes scheduled remote consultations with the treating Indian oncologist, coordination with local Ethiopian oncologists, and medication continuity management.

Follow-up structure typically includes consultations at 3 months, 6 months, and 12 months after treatment, then annually for the next four years, then less frequently for long-term survivors. Remote consultations are conducted via WhatsApp video call or secure file sharing for imaging and lab results.

Local coordination is essential. DocTrePat helps connect Ethiopian patients with oncologists at Tikur Anbessa, Bethel Hospital, or private clinics in Addis Ababa for routine blood work, imaging, and physical examinations. The local Ethiopian doctor receives a comprehensive care plan from the treating Indian oncologist and updates the Indian team on findings.

Medication continuity is managed actively. Most cancer medications used in India are available in Ethiopia, though sometimes at higher cost or with intermittent supply. DocTrePat helps families source medications, arrange shipment from India where necessary, and coordinate with local pharmacies for ongoing prescriptions. The assigned case manager who guided the patient through treatment remains the patient's point of contact for any follow-up questions or concerns for the full survivorship period.

Get Expert Cancer Treatment Guidance from India

Every cancer case is unique. Share your medical reports with our team and receive a personalized treatment plan, hospital recommendation, and detailed cost estimate from leading Indian oncologists within 48 hours.

Free Medical Report Review
Personalized Cost Estimate in Birr, USD & INR
Expert Second Opinion from Top Cancer Specialists
Medical Visa & Travel Assistance for Ethiopian Patients

WhatsApp Us: +91 96259 33363
Get Your Free Second Opinion Today